Literature DB >> 7769940

Treatment of vocal fold granuloma using botulinum toxin type A.

S Nasri1, J A Sercarz, T McAlpin, G S Berke.   

Abstract

Contact granuloma of the vocal folds has been associated with abnormal use of the voice, and acid reflux may exacerbate the inflammatory process. Treatments have included voice therapy and antireflux measures. Surgical excision is considered in patients who do not respond to medical management. Localized injections of botulinum toxin type A (BOTOX) have been effective in patients with disorders of muscular control in the head and neck. In this study, granulomas resolved in six patients who underwent injection of the affected vocal folds. Botulinum toxin type A is probably successful because it prevents forceful closure of the arytenoids during phonation and coughing. Localized injection of this neurotoxin is promising both as an initial treatment and as an alternative treatment in patients who do not respond to standard therapy or who are poor surgical candidates.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769940     DOI: 10.1288/00005537-199506000-00005

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  [Laryngeal granuloma. Aetiology, clinical signs, diagnostic procedures, and treatment].

Authors:  C Storck; M Brockmann; E Zimmermann; D Nekahm-Heis; P G Zorowka
Journal:  HNO       Date:  2009-10       Impact factor: 1.284

2.  Potassium titanyl phosphate laser treatment of intubation vocal granuloma.

Authors:  Deng-Shan Lin; Shu-Chu Cheng; Wan-Fu Su
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-03-04       Impact factor: 2.503

3.  Vocal process granuloma: clinical characterization, treatment and evolution.

Authors:  Elza Maria Lemos; Luiz Ubirajara Sennes; Rui Imamura; Domingos H Tsuji
Journal:  Braz J Otorhinolaryngol       Date:  2005-12-15

Review 4.  Treatment of post-intubation laryngeal granulomas: systematic review and proportional meta-analysis.

Authors:  Caroline Fernandes Rimoli; Regina Helena Garcia Martins; Daniele Cristina Catâneo; Rui Imamura; Antonio José Maria Catâneo
Journal:  Braz J Otorhinolaryngol       Date:  2018-04-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.